In humans, mutations in c-Raf are associated with cardiac hypertrophy in genetic disorders such as Noonan syndrome suggesting an important role of c-Raf in pathophysiological modulation of cardiac hypertrophy [15]. This evidence concerns the gene RAF1 and hereditary disease.